Company: SPEG
Filing Date: 2025-06-20
Form Type: S-1/A
Source: 0001213900-25-055713
Chunk: 232

Company: Silver Pegasus Acquisition Corp.
Filing Date: 2025-06-20
Form: S-1/A
Chunk 232
---
 with Ivanhoe Capital Acquisition Corp., a SPAC (“Ivanhoe”), in February 2022. On January11, 2021, Ivanhoe consummated its initial public offering of 27,600,000 units, including the issuance of 3,600,000 Units as a result of the underwriters’ exercise of their over -allotmentoption in full. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one -thirdof one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $276,000,000. On February1, 2022, Ivanhoe had a special meeting to approve its business combination and a total of 22,455,850 Class A Ordinary Shares (81% of the outstanding Class A Ordinary Shares) were presented for redemption in connection with the General Meeting leaving approximately $51.45million remaining in Ivanhoe’s trust account following Redemptions. Atlantic Coastal Acquisition Corp. II (ACAB)Mr.Eisenberg currently serves on the Board of Directors of NASDAQ -listedbiotechnology company AbPro). AbPro had merged with ACAB, where from 2021 through 2024, Mr.Eisenberg served as a Director and Chief Strategy Officer. ACAB consummated its initial public offering on January19, 2022 generating gross proceeds of $300million with a deadline of to consummate a business combination. On April18, 2023, in connection with stockholder approval to extend the date by which ACAB must consummate a business combination to December19, 2023, holders of an aggregate of 26,564,308shares of Series A common stock redeemed their shares. On December15, 2023, the stockholders of ACAB approved the proposal to extend the day where ACAB must consummate a business combination to March19, 2024, with monthly extensions to September19, 2024. 825,225shares of Series A common stock were redeemed. On September19, 2024, the stockholders approved to extend the date by which ACAB must complete its initial business combination from September19, 2024 to October